Skip to Content

APO 131 (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)

Pill with imprint APO 131 is Red, Round and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Apotex Corp..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 131

Carbidopa and levodopa extended release 25 mg / 100 mg APO 131
Carbidopa and levodopa extended release 25 mg / 100 mg APO 131
Carbidopa and levodopa extended release 25 mg / 100 mg APO 131

Carbidopa and Levodopa Extended Release

Imprint
APO 131
Strength
25 mg / 100 mg
Color
Red
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Apotex Corp.
National Drug Code (NDC)
60505-0131
Inactive Ingredients
hypromelloses, magnesium stearate, ferric oxide red

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "APO 131"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.